Halozyme Therapeutics | HALO - Debitur Perdagangan

Harga Saham
66.31
Perubahan Harian
-1.51 -2.23%
Bulanan
3.14%
Tahunan
8.01%
Q2 Perkiraan
65.97




Debitur Perdagangan Perubahan Tanggal
Acadia Pharmaceuticals USD 148.23M 8.79M 2025-12
Agios Pharmaceuticals USD 10.58M 5.55M 2025-12
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amarin USD 126.83M 477K 2025-12
Amgen USD 9.57B 1.08B 2025-12
Baxter International USD 2.01B 231M 2025-12
Cara Therapeutics USD 2.24M 2.26M 2025-03
Cytokinetics USD 1.81M 6.6M 2025-09
DBV Technologies USD 15.97M 279K 2025-09
Eli Lilly USD 19.46B 2.25B 2025-09
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Halozyme Therapeutics USD 441.27M 95.24M 2025-12
Intrexon USD 1.02M 559K 2024-06
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
MannKind USD 38.37M 20.98M 2025-12
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
United Therapeutics USD 350.2M 52.5M 2025-12
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12